This inventor holds 2 USPTO granted patents. Top assignee: University College London. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxford, GB (1999)
- London, GB (2000)
Company Filing History:
Years Active: 1999-2000
Title: Thomas W. Rademacher: Innovator in Glycosidase Inhibitors
Introduction
Thomas W. Rademacher is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of glycosidase inhibitors. With a total of 2 patents, Rademacher's work has implications for treating serious medical conditions.
Latest Patents
Rademacher's latest patents include innovative research on hormone and growth factor phosphoglycokine mimetics derived from mycobacterium. One of his key inventions focuses on the use of glycosidase inhibitors. This invention is directed towards inhibiting the conversion of a pro-toxin to a toxin by a glycosidase enzyme. Specifically, it relates to the treatment of malaria, endotoxic shock, or septic shock.
Career Highlights
Rademacher is affiliated with University College London, where he continues to advance his research. His work has garnered attention for its potential to impact public health positively.
Collaborations
Some of his notable coworkers include Hugo Norberto Caro and Graham A. Rook. Their collaborative efforts contribute to the innovative research environment at University College London.
Conclusion
Thomas W. Rademacher is a distinguished inventor whose work in glycosidase inhibitors holds promise for treating critical health issues. His contributions to the field of biochemistry are noteworthy and continue to inspire further research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile